Roule Vincent, Lemaitre Adrien, Sabatier Rémi, Lognoné Thérèse, Dahdouh Ziad, Berger Ludovic, Milliez Paul, Grollier Gilles, Montalescot Gilles, Beygui Farzin
Cardiology Department, University Hospital of Caen, avenue Côte-de-Nacre, 14033 Caen, France.
ACTION academic group, Institut de Cardiologie, Pitié-Salpêtrière University Hospital, 75013 Paris, France.
Arch Cardiovasc Dis. 2015 Nov;108(11):563-75. doi: 10.1016/j.acvd.2015.06.005. Epub 2015 Sep 11.
The transradial approach for percutaneous coronary intervention (PCI) is associated with a better outcome in myocardial infarction (MI), but patients with cardiogenic shock (CS) were excluded from most trials.
To compare outcomes of PCI for MI-related CS via the transradial versus transfemoral approach.
A prospective cohort of 101 consecutive patients admitted for PCI for MI-related CS were treated via the transradial (n=74) or transfemoral (n=27) approach. Cox proportional hazards models adjusted for prespecified variables and a propensity score for approach were used to compare mortality, death/MI/stroke and bleeding between the two groups. A complementary meta-analysis of six studies was also performed.
Patients in the transradial group were younger (P=0.039), more often male (P=0.002) and had lower GRACE and CRUSADE scores (P=0.003 and 0.001, respectively) and rates of cardiac arrest before PCI (P=0.009) and mechanical ventilation (P=0.006). Rates of PCI success were similar. At a mean follow-up of 756 days, death occurred in 40 (54.1%) patients in the transradial group versus 22 (81.5%) in the transfemoral group (adjusted hazard ratio [HR]: 0.49, 95% confidence interval [CI] 0.28-0.84; P=0.012). The transradial approach was associated with reduced rates of death/MI/stroke (adjusted HR: 0.53, 95%CI: 0.31-0.91; P=0.02) and major bleeding (adjusted HR: 0.34, 95%CI: 0.13-0.87; P=0.02). The meta-analysis confirmed the benefit of transradial access in terms of mortality (relative risk [RR]: 0.63, 95%CI: 0.58-0.68) and major bleeding (RR: 0.43, 95%CI: 0.32-0.59).
The transradial approach in the setting of PCI for ischaemic CS is associated with a dramatic reduction in mortality, ischaemic and bleeding events, and should be preferred to the transfemoral approach in radial expert centres.
经桡动脉途径进行经皮冠状动脉介入治疗(PCI)在心肌梗死(MI)中预后较好,但大多数试验将心源性休克(CS)患者排除在外。
比较经桡动脉与经股动脉途径对与MI相关的CS进行PCI的预后。
对101例因与MI相关的CS入院接受PCI的连续患者进行前瞻性队列研究,分别采用经桡动脉途径(n = 74)或经股动脉途径(n = 27)进行治疗。使用针对预先设定变量和途径倾向评分进行调整的Cox比例风险模型,比较两组之间的死亡率、死亡/心肌梗死/卒中以及出血情况。还对六项研究进行了补充荟萃分析。
经桡动脉组患者更年轻(P = 0.039),男性比例更高(P = 0.002),GRACE和CRUSADE评分更低(分别为P = 0.003和0.001),PCI前心脏骤停发生率(P = 0.009)和机械通气率(P = 0.006)更低。PCI成功率相似。平均随访756天时,经桡动脉组40例(54.1%)患者死亡,经股动脉组22例(81.5%)患者死亡(调整后风险比[HR]:0.49,95%置信区间[CI] 0.28 - 0.84;P = 0.012)。经桡动脉途径与死亡/心肌梗死/卒中发生率降低相关(调整后HR:0.53,95%CI:0.31 - 0.91;P = 0.02),大出血发生率也降低(调整后HR:0.34,95%CI:0.13 - 0.87;P = 0.02)。荟萃分析证实经桡动脉途径在死亡率(相对风险[RR]:0.63,95%CI:0.58 - 0.68)和大出血(RR:0.43,95%CI:0.32 - 0.59)方面的益处。
在缺血性CS的PCI治疗中,经桡动脉途径与死亡率、缺血和出血事件的显著降低相关,在桡动脉技术熟练的中心应优先于经股动脉途径。